Adverse Events at 1 Month Following Medication Initiation for Opioid Use Disorder Among Adolescents and Young Adults
Excluding injection site reactions, there were no significant differences in the likelihood of reporting an AE 1 month after receiving LAI-NTX, buprenorphine, and no medications. LAI-naltrexone should be among the medications offered for the treatment of OUD in youth.
Authors
- Kevin E. O’Grady (ORCID: https://orcid.org/0000-0001-6565-7802)
- Jan Gryczynski (ORCID: https://orcid.org/0000-0001-5920-4057)
- Mishka Terplan (ORCID: https://orcid.org/0000-0002-2489-2942)
- Laura B. Monico (ORCID: https://orcid.org/0000-0002-1504-4968)
- Robert P. Schwartz (ORCID: https://orcid.org/0000-0002-4707-5726)
- Shannon Gwin Mitchell (ORCID: https://orcid.org/0000-0002-2841-1085)
- Marc Fishman (ORCID: https://orcid.org/0000-0001-6764-6410)
Institutions
- Friends Research Institute (US)
- University of Maryland, College Park (US)
Publication Details
- Journal
- Substance Use & Addiction Journal
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1177/29767342241275738
- Citations
- 1
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.54